Palmoplantar Pustular Psoriasis Is Associated with Missense Variants in CARD14, but Not with Loss-of-Function Mutations in IL36RN in European Patients.
about
Palmoplantar Psoriasis and Palmoplantar Pustulosis: Current Treatment and Future Prospects.CARD14 alterations in Tunisian patients with psoriasis and further characterization in European cohorts.Update on psoriasis immunopathogenesis and targeted immunotherapy.Psoriasis-Specific RNA Isoforms Identified by RNA-Seq Analysis of 173,446 Transcripts.Monogenic Autoinflammatory Diseases with Mendelian Inheritance: Genes, Mutations, and Genotype/Phenotype Correlations.What do we know about palmoplantar pustulosis?European consensus statement on phenotypes of pustular psoriasis.Mutation analysis of IL36RN gene in Japanese patients with palmoplantar pustulosis.Palmar plantar pustulosis responding to high-dose folic acid plus vitamins B6 and B12.Acute generalized exanthematous pustulosis and polyarthritis associated with a novel CARD14 mutation.[Pustular psoriasis].The E3 Ubiquitin Ligase RNF7 Negatively Regulates CARD14/CARMA2sh Signaling.Pathogenesis of psoriasis and development of treatment.Pustular psoriasis and related pustular skin diseases.Evidence for genetic overlap between adult onset Still's disease and hereditary periodic fever syndromes.Association analysis of psoriasis vulgaris and psoriatic arthritis with loss-of-function mutations in IL36RN in German patients.The Interleukin-23/Interleukin-17 Axis Links Adaptive and Innate Immunity in Psoriasis.CARD14/CARMA2 Signaling and its Role in Inflammatory Skin DisordersClinical and Genetic Heterogeneity of Mutations in Psoriatic Skin Disease
P2860
Q30251512-14A4F173-10FC-4F93-AB54-8826C96295AAQ33726533-F88AC018-3338-43EF-BF83-B9B839346FC4Q36445919-71BE0548-B253-4837-97F4-03059ABF477FQ37318036-0A42965B-EF95-4D79-BF1F-0F0D01A1A1D1Q37733733-3DD57970-E05A-4132-A3AD-10A81635F8C2Q38926801-9924B915-4C40-47CB-BCA9-4E513AA1AC30Q39353851-3CAB7127-ACEC-4AB8-98DA-C9BB18A356D0Q39472493-4C1D6EBB-D983-4A37-BADC-90586D44853CQ39560202-573CBC91-604E-4782-AB1C-69EA33EC42BDQ40044596-4A62C8D6-5ECF-49D5-9E67-611C15E1B387Q40653524-58584570-D81F-4E1E-AA47-45F89D15F3F6Q46250292-02287B81-AB7C-42BE-AE4F-2C46900EB66CQ48144635-6B51095E-2564-4E6C-815A-1C54DD25422DQ48245430-EE55CDD5-6B72-4C77-B267-09C629AF53B4Q48266470-273698D9-5400-4B40-8A9E-AB8CC2BF3C43Q53778589-8A4F86C5-DA31-42F2-9D12-ADD1478568EEQ55386458-9381C93C-FA81-4E05-A28A-38AE64BD5FA7Q57491439-84738B28-8CAB-41DF-90D5-3E92EE457E39Q58553821-D7BE7333-0318-4735-81F4-9B0364A6E13D
P2860
Palmoplantar Pustular Psoriasis Is Associated with Missense Variants in CARD14, but Not with Loss-of-Function Mutations in IL36RN in European Patients.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Palmoplantar Pustular Psoriasi ...... n IL36RN in European Patients.
@en
Palmoplantar Pustular Psoriasi ...... n IL36RN in European Patients.
@nl
type
label
Palmoplantar Pustular Psoriasi ...... n IL36RN in European Patients.
@en
Palmoplantar Pustular Psoriasi ...... n IL36RN in European Patients.
@nl
prefLabel
Palmoplantar Pustular Psoriasi ...... n IL36RN in European Patients.
@en
Palmoplantar Pustular Psoriasi ...... n IL36RN in European Patients.
@nl
P2093
P50
P356
P1476
Palmoplantar Pustular Psoriasi ...... n IL36RN in European Patients.
@en
P2093
Ansgar Weyergraf
Arnd Jacobi
Dagmar Wilsmann-Theis
Harald Burkhardt
Heiko Traupe
Michael Müller
Michael Sticherling
Regina Renner
Rotraut Mössner
Sabine Löhr
P2888
P304
P356
10.1038/JID.2015.186
P407
P577
2015-05-19T00:00:00Z